Patent applications and USPTO patent grants for HUANG; Liyue.The latest application filed is for "small molecule menin inhibitors".
Patent | Date |
---|---|
Small Molecule Menin Inhibitors App 20210353610 - WANG; Shaomeng ;   et al. | 2021-11-18 |
Pyrrolo[2,3-C]pyridines and related analogs as LSD-1 inhibitors Grant 11,168,082 - Wang , et al. November 9, 2 | 2021-11-09 |
Piperidines As Menin Inhibitors App 20210198237 - Wang; Shaomeng ;   et al. | 2021-07-01 |
Piperidines as covalent menin inhibitors Grant 11,045,448 - Wang , et al. June 29, 2 | 2021-06-29 |
Peptidomimetic Inhibitors Of The Wdr5-mll Interaction App 20210130401 - Wang; Shaomeng ;   et al. | 2021-05-06 |
Piperidine Compounds As Covalent Menin Inhibitors App 20210115018 - WANG; Shaomeng ;   et al. | 2021-04-22 |
Piperidines as menin inhibitors Grant 10,899,738 - Wang , et al. January 26, 2 | 2021-01-26 |
Pyrrolo[2,3-c]pyridines And Related Analogs As Lsd-1 Inhibitors App 20200157091 - Wang; Shaomeng ;   et al. | 2020-05-21 |
Piperidines As Covalent Menin Inhibitors App 20200022953 - Wang; Shaomeng ;   et al. | 2020-01-23 |
Piperidines As Menin Inhibitors App 20190152947 - Wang; Shaomeng ;   et al. | 2019-05-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.